CIK: 0001560009
Total reported value
$141.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | GKOS | Glaukos CORP | Stock-Healthcare | 43.59% | — | — | |
| 2 | CLVSEUR | Clovis Oncology INC | Stock-Other | 21.49% | — | — | |
| 3 | OCUL | Ocular Therapeutix INC | Stock-Other | 17.86% | — | — | |
| 4 | FPRX | Five Prime Therapeutics INC | Stock-Other | 9.64% | — | — | |
| 5 | AKAOQ | Achaogen INC | Stock-Other | 4.23% | — | — | |
| 6 | ✓ | Biotie Therapies Oyj | Stock-Other | 2.02% | — | — | |
| 7 | CBAYUSD | Cymabay Therapeutics INC | Stock-Other | 1.17% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | CBAYUSD | Cymabay Therapeutics INC | -2.4% | — | Unchanged |
| 2 | ✓ | Biotie Therapies Oyj | -4.8% | — | Unchanged |
| 3 | AKAOQ | Achaogen INC | -5.6% | — | Unchanged |
| 4 | CLVSEUR | Clovis Oncology INC | -23.9% | — | Unchanged |
| 5 | FPRX | Five Prime Therapeutics INC | -24.8% | — | Unchanged |
| 6 | GKOS | Glaukos CORP | — | NEW | New buy |
| 7 | OCUL | Ocular Therapeutix INC | — | NEW | New buy |